ArticleThe European respiratory journal2022

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.

Mark Toshner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.